Display options
Share it on

Saudi J Ophthalmol. 2017 Jul-Sep;31(3):156-161. doi: 10.1016/j.sjopt.2017.05.017. Epub 2017 Jun 14.

Fat-removal orbital decompression for thyroid associated orbitopathy: The right procedure for the right patient.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society

Eman Al-Sharif, Adel H Alsuhaibani

Affiliations

  1. Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

PMID: 28860913 PMCID: PMC5569338 DOI: 10.1016/j.sjopt.2017.05.017

Abstract

Orbital decompression is an effective and invaluable procedure for addressing some of the chronic manifestations of Graves' Ophthalmopathy (GO) such as exophthalmos and orbital congestion. Fat-removal orbital decompression (FROD) started to gain popularity after its introduction in the late 20th century. Among the therapeutic armamentarium of techniques and approaches available for orbital decompression, FROD has proven its efficacy and safety in addition to its ability to reduce proptosis in a relatively predictable manner. In addition, postoperative complications occurring after FROD are generally considered to be less frequent and less serious compared to bone-removal orbital decompression (BROD). Nevertheless, despite of FROD's high benefit-to-risk ratio, proper selection of patients based on meticulous preoperative assessment, including imaging, is of paramount importance to achieve optimal functional and aesthetic results. Although up till now there is still no consensus regarding the procedure of choice in GO patients, FROD is an important option to consider in this subset of patients.

Keywords: Bone-removal orbital decompression (BROD); Fat-removal orbital decompression (FROD); Graves’ ophthalmopathy (GO); Proptosis; Thyroid eye disease (TED)

References

  1. J Craniomaxillofac Surg. 2012 Feb;40(2):134-41 - PubMed
  2. Indian J Ophthalmol. 2015 Nov;63(11):847-53 - PubMed
  3. Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):935-9 - PubMed
  4. Eur J Ophthalmol. 2004 May-Jun;14(3):193-9 - PubMed
  5. Int Ophthalmol. 2015 Jun;35(3):325-9 - PubMed
  6. Am J Ophthalmol. 2011 Mar;151(3):465-9.e1 - PubMed
  7. Semin Plast Surg. 2017 Feb;31(1):40-45 - PubMed
  8. Ann Plast Surg. 2011 Feb;66(2):192-5 - PubMed
  9. Jpn J Ophthalmol. 2010 Mar;54(2):174-5 - PubMed
  10. Middle East Afr J Ophthalmol. 2011 Jan;18(1):80-1 - PubMed
  11. Plast Reconstr Surg. 2007 Jul;120(1):109-23 - PubMed
  12. N Engl J Med. 2010 Feb 25;362(8):726-38 - PubMed
  13. Bull Acad Natl Med. 2003;187(9):1649-58; discussion 1659-60 - PubMed
  14. Am J Ophthalmol. 2008 Apr;145(4):755-9 - PubMed
  15. J Craniomaxillofac Surg. 2012 Oct;40(7):621-5 - PubMed
  16. Ophthal Plast Reconstr Surg. 2006 Mar-Apr;22(2):92-5 - PubMed
  17. Plast Reconstr Surg. 1991 Apr;87(4):627-41; discussion 642-3 - PubMed
  18. Acta Otorhinolaryngol Ital. 2016 Aug;36(4):265-274 - PubMed
  19. Br J Ophthalmol. 2000 Jun;84(6):600-5 - PubMed
  20. Endocr Rev. 1993 Dec;14(6):747-93 - PubMed
  21. HNO. 2010 Jan;58(1):8-10, 12-4 - PubMed
  22. J Clin Endocrinol Metab. 2011 Feb;96(2):320-32 - PubMed
  23. Ophthal Plast Reconstr Surg. 2015 May-Jun;31(3):215-8 - PubMed
  24. Eur J Endocrinol. 2011 May;164(5):649-55 - PubMed
  25. Ophthal Plast Reconstr Surg. 2012 Sep-Oct;28(5):346-9 - PubMed
  26. Endokrynol Pol. 2016;67(2):166-73 - PubMed
  27. Ophthal Plast Reconstr Surg. 2017 May/Jun;33(3):189-195 - PubMed
  28. Curr Eye Res. 2016;41(2):159-64 - PubMed
  29. Thyroid. 2002 Oct;12(10):855-60 - PubMed
  30. Ophthal Plast Reconstr Surg. 2004 Sep;20(5):347-51 - PubMed
  31. Br J Ophthalmol. 2011 Dec;95(12):1625-30 - PubMed
  32. Ophthal Plast Reconstr Surg. 2011 May-Jun;27(3):158-63 - PubMed
  33. Trans Am Ophthalmol Soc. 2005;103:368-411 - PubMed
  34. Am J Ophthalmol. 2011 Mar;151(3):399-400 - PubMed
  35. Adv Ther. 2015 Jul;32(7):595-611 - PubMed
  36. Am J Ophthalmol. 1996 Feb;121(2):200-6 - PubMed
  37. Am J Ophthalmol. 1996 Mar;121(3):284-90 - PubMed

Publication Types